<DOC>
	<DOCNO>NCT01251848</DOCNO>
	<brief_summary>The study assess sitaxsentan ritonavir affect blood level coadministered .</brief_summary>
	<brief_title>Drug Interaction Between Ritonavir And Sitaxsentan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Healthy male subject and/or woman nonchild bear potential . Subjects ( teratogenic risk sitaxsentan ) age 21 55 year , inclusive . Signed informed consent . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . History significant alcohol drug use . Has hepatic dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Sitaxentan</keyword>
	<keyword>ritonavir</keyword>
	<keyword>drug interaction</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>